Form 4 for KALA KALA BIO, Inc.
Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-15 · accession 0001415889-25-017611 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-17 | 2025-06-15 | KALA | KOVEN ANDREW I | Dir | A - Grant | $0.00 | +3,050 | 17.0K | +22% | $0 |
| D | 2025-06-17 | 2025-06-15 | KALA | KOVEN ANDREW I | Dir | A - Grant | $0.00 | +6,850 | 6,850 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-15 | A | A | 3,050 | $0.00 | 16,972 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026. (F2) Includes 8,061 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2025-06-15 | A | A | 6,850 | $0.00 | 6,850 | D | $4.30 · — to 2035-06-14 | 6,850 Common Stock | (F3) This option was granted on June 15, 2025 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026. |